Given that ZNF217, a transcriptional activator of TGF-β, promotes EMT in breast cancer8 and that TGF-β signaling is elevated in keloids, we surmised that ZNF217 might modulate the autocrine secretion of TGF-β2 in keloids. This evidence concerns the gene ZNF217 and keloid.